¼¼°èÀÇ Ã¼¿Ü Àü»ç ÅÛÇø´ ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, Áúº´ À¯Çüº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
In-vitro Transcription Templates Market, By Product, By Application, By Disease Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1565707
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 269 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,443,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,357,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,724,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¼¼°è ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå ±Ô¸ð´Â 2023³â 2¾ï 5,143¸¸ ´Þ·¯·Î 2024-2032³â ¿¬Æò±Õ 21.09% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå - ½ÃÀå ¿ªÇÐ

RNA ±â¹Ý Ä¡·áÁ¦ ¹× ¹é½Å¿¡ ´ëÇÑ ¼ö¿ä È®´ë, »ý¸í°øÇÐ ¿¬±¸ Áõ°¡µµ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»ó

¼ÒºÐÀÚ °£¼· RNA(siRNA)¿Í ¾ÈƼ¼¾½º ¿Ã¸®°í´ºÅ¬·¹¿ÀƼµå(ASO)¸¦ Æ÷ÇÔÇÑ RNA ±â¹Ý Ä¡·áÁ¦ÀÇ °³¹ß·Î °íǰÁú RNA »ý»ê¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. È­ÀÌÀÚ ¹ÙÀÌ¿ÀÅØ°ú Moderna¿Í °°Àº COVID-19¿ë mRNA ¹é½ÅÀº ü¿Ü Àü»ç(In-vitro transcription, IVT) ÅÛÇø´¿¡ ´ëÇÑ °ü½ÉÀ» Å©°Ô Áõ°¡½ÃÄ×À¸¸ç, ü¿Ü Àü»ç´Â mRNA ¹é½ÅÀÇ ½Å¼ÓÇÑ ¼³°è ¹× »ý»êÀÌ °¡´ÉÇϱ⠶§¹®¿¡ ÀǾàǰ °³¹ß¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. CRISPR-Cas9¿Í °°Àº À¯ÀüÀÚ ÆíÁý µµ±¸ÀÇ µîÀåÀ¸·Î ü¿Ü Àü»ç´Â À¯Àüü ÆíÁý¿¡ ÇʼöÀûÀÎ °¡À̵å RNA(gRNA) »ý¼º¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù.

¸ÂÃãÇü ÀÇ·á°¡ ¹ßÀüÇÔ¿¡ µû¶ó ¾Ï ¸é¿ªÄ¡·á¿Í °°Àº ¸ÂÃãÇü Ä¡·á¸¦ À§ÇÑ ¸ÂÃãÇü RNA¸¦ »ý»êÇÒ ¼ö ÀÖ´Â ´É·ÂÀº È¿À²ÀûÀÎ IVT ÅÛÇø´ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À¼¾¼­, »ý¸í°øÇÐ ÀÀ¿ë ¹× »õ·Î¿î »ý¹°ÇÐÀû ȸ·Î¸¦ À§ÇÑ RNA¸¦ È¿À²ÀûÀ¸·Î »ý»êÇØ¾ß ÇÏ´Â Çʿ伺ÀÌ Àü»ç ÅÛÇø´¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áö¼ÓÀûÀ¸·Î µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷Àº ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Àü»ç ÅÛÇø´¿¡ ´ëÇÑ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °úÇÐÀÚµéÀº À¯ÀüÀÚ ¹ßÇö, ´Ü¹éÁú ÇÕ¼º ¹× ¼¼Æ÷ ¸ÞÄ¿´ÏÁòÀ» ¿¬±¸Çϱâ À§ÇØ Ã¼¿Ü Àü»ç ÅÛÇø´À» »ç¿ëÇϰí ÀÖ½À´Ï´Ù.

ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 21.09%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦Ç°º°·Î´Â DNA ÅÛÇø´ ºÎ¹®ÀÌ Àü»ç¸¦ ÃËÁøÇÏ´Â ³ôÀº È¿À²¼ºÀ¸·Î ÀÎÇØ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

¿ëµµº°·Î´Â COVID-19 ¹× ±âŸ ¹ÙÀÌ·¯½º °¨¿°ÁõÀÇ È®»êÀ¸·Î ÀÎÇØ ¹é½Å ºÎ¹®ÀÌ 2023³â ÁÖ¿ä ÀÀ¿ë ºÐ¾ß·Î ºÎ»óÇß½À´Ï´Ù.

Áúº´ À¯Çüº°·Î´Â Æó¾Ï, ¹éÇ÷º´, À¯¹æ¾Ï µîÀÇ À¯ÇàÀ¸·Î 2023³â¿¡´Â ¾Ï ºÐ¾ß°¡ ÁÖ¿ä Áúº´ À¯ÇüÀ¸·Î ºÎ»óÇß½À´Ï´Ù.

Áö¿ªº°·Î´Â 2023³â ºÏ¹Ì°¡ ÁÖ¿ä ¼öÀÍ¿øÀ̾ú½À´Ï´Ù. ÀÌ´Â ¿¬±¸°³¹ß°ú ½Å¾à°³¹ß¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿ø ´öºÐÀÔ´Ï´Ù.

ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

ü¿Ü Àü»ç ÅÛÇø´ ¼¼°è ½ÃÀåÀº Á¦Ç°, ÀÀ¿ë ºÐ¾ß, Áúº´ À¯Çü ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç°º°·Î DNA ÅÛÇø´, RNA ÅÛÇø´, ÅÛÇø´ ¹× Àü»ç ŰƮ, ±âŸ µî 4°¡Áö ¹üÁÖ·Î ³ª´µ¸ç, DNA ÅÛÇø´ ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. DNA ÅÛÇø´Àº ³ôÀº È¿À²¼º°ú ½ÃÄö½Ì ¹× Àü»ç °úÁ¤¿¡¼­ °ß°íÇÑ Æ¯¼ºÀ» °¡Áö°í ÀÖ¾î ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ¿ëµµº°·Î ¹é½Å°ú Ä¡·áÁ¦ µÎ °¡Áö·Î ³ª´¹´Ï´Ù. ¹é½Å ºÎ¹®ÀÌ ½ÃÀåÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù. ¹é½ÅÀº ÁÖ·Î ¹ÙÀÌ·¯½º °¨¿°À» Ç¥ÀûÀ¸·Î »ï´Â µ¥ »ç¿ëµÇ¸ç ´Ù¸¥ À¯Çüº¸´Ù ´õ È¿°úÀûÀ̱⠶§¹®¿¡ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

Áúº´ À¯Çüº°·Î´Â ¾Ï, °¨¿°¼º Áúȯ, À¯Àü¼º Áúȯ, »ýȰ½À°üº´, ±âŸ 5°¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù. ¾Ï ºÎ¹®Àº ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ³ôÀº ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Æó¾Ï, À¯¹æ¾Ï, ¹éÇ÷º´ÀÇ À¯º´·ü Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» º¸¿ÏÇϰí ÀÖ½À´Ï´Ù.

ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¼¼°è ½ÃÀå¿¡¼­ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ƯÈ÷ RNA ±â¹Ý Ä¡·áÁ¦ ¹× ¹é½Å °³¹ß¿¡¼­ È®°íÇÑ »ý¸í°øÇÐ ¹× Á¦¾à ºÎ¹®À» º¸À¯Çϰí ÀÖ¾î ¼¼°è ½ÃÀåÀ» Àå¾ÇÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â Áß±¹ÀÌ »ý¸í°øÇÐ ºÐ¾ßÀÇ ¼ºÀå, RNA ±â¹Ý Ä¡·áÁ¦¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, »ý¸í°øÇÐ ¿¬±¸°³¹ß¿¡ ´ëÇÑ Á¤ºÎ Áö¿øÀ¸·Î ÀÎÇØ IVT ÅÛÇø´ ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀ¸·Î ºü¸£°Ô ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾî Çõ½Å¿¡ ´ëÇÑ Á¤ºÎÀÇ ÁýÁß°ú ¼¼°è Á¦¾à»ç¿ÍÀÇ ÆÄÆ®³Ê½ÊÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå - °æÀï »óȲ:

ü¿Ü Àü»ç(IVT) ÅÛÇø´ ½ÃÀåÀº »ý¸í°øÇÐ ¹× Á¦¾à ¾÷°èÀÇ ÁÖ¿ä ±â¾÷µéÀÌ RNA ±â¹Ý ±â¼ú Çõ½Å¿¡ ÁýÁßÇϸ鼭 °æÀïÀÌ Ä¡¿­ÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº RNA »ý»êÀ» À§ÇÑ °íǰÁú Àü»ç ÅÛÇø´ °³¹ß¿¡ ÅõÀÚÇÏ¿© mRNA ¹é½Å, RNA ±â¹Ý Ä¡·áÁ¦, À¯ÀüÀÚ ÆíÁý µîÀÇ ºÐ¾ß¿¡¼­ ÁøÀüÀ» ÀÌ·ç±â À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. TriLink, Aldevron, Merck µî ÁÖ¿ä ±â¾÷µéÀº Á¦¾àȸ»ç¿Í Á¦ÈÞÇÏ¿© RNA ±â¹Ý ¹é½Å ¹× Ä¡·áÁ¦ »ý»ê¿¡ ÇʼöÀûÀÎ IVT ±¸¼º¿ä¼Ò¸¦ °ø±ÞÇϰí ÀÖÀ¸¸ç, TriLink, Aldevron, Merck µîÀº mRNA ¹é½Å ¹× RNA ±â¹Ý ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Æ¯È÷ °íǰÁú RNA »ý»êÀ» À§ÇÑ Á¦Á¶ ´É·Â È®´ë¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù.

2023³â 9¿ù, ¸ÓÅ©´Â mRNAÀÇ °³¹ß, Á¦Á¶, »ó¾÷È­ ¹× Á¦Ç° Å×½ºÆ®ÀÇ ¿ÏÀü ÅëÇÕ ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ÃÖÃÊÀÇ CTDMO°¡ µÇ¾ú½À´Ï´Ù.

2023³â ÀÇÇבּ¸À§¿øÈ¸(MRC)¿Í »ý¸í°øÇÐ ¹× »ý¹°°úÇבּ¸À§¿øÈ¸(BBSRC) µî ¿µ±¹ ¿¬±¸À§¿øÈ¸´Â RNA »ý¹°ÇÐ ¹× À¯ÀüüÇÐ ±âÃÊ ¿¬±¸¿Í ÀÀ¿ë ¿¬±¸¿¡ ¸¹Àº ÀÚ±ÝÀ» ¹èÁ¤Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ü¿Ü Àü»ç ÅÛÇø´ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ü¿Ü Àü»ç ÅÛÇø´ ¾÷°è Á¶»ç

Á¦5Àå ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå »óȲ

Á¦7Àå ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå - Á¦Ç°º°

Á¦8Àå ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå - ¿ëµµº°

Á¦9Àå ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå - Áúȯ À¯Çüº°

Á¦10Àå ü¿Ü Àü»ç ÅÛÇø´ ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ü¿Ü Àü»ç ÅÛÇø´ ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

In-vitro Transcription Templates Market size was valued at USD 251.43 Million in 2023, expanding at a CAGR of 21.09% from 2024 to 2032.

In-vitro transcription templates are DNA sequences used to synthesize RNA in a controlled laboratory setting outside of a living organism. These templates serve as the blueprints for RNA synthesis and are essential in experiments where researchers want to produce specific RNA molecules.

In-vitro Transcription Templates Market- Market Dynamics

Growing demand from RNA-based therapeutics & vaccines and increasing research in biotech is also expected to propel market demand

The development of RNA-based therapeutics, including small interfering RNA (siRNA) and antisense oligonucleotides (ASOs), has increased demand for high-quality RNA production. mRNA vaccines, like those developed for COVID-19 disease like Pfizer-BioNTech and Moderna, have significantly boosted interest in in-vitro transcription (IVT) templates. The ability to rapidly design and produce mRNA vaccines has made in-vitro transcription crucial in pharmaceutical development. The rise of gene-editing tools like CRISPR-Cas9 uses in-vitro transcription to generate guide RNA (gRNA), which is critical for genome editing applications.

As personalized medicine evolves, the ability to produce tailor-made RNA for individualized treatments like cancer immunotherapies drives the demand for efficient IVT template technology. The need for efficient production of RNA for biosensors, bioengineering applications, and novel biological circuits continues to support the demand for transcription templates. In addition, the pharmaceutical and biotechnology industries are investing heavily in R&D, which supports the demand for transcription templates. Scientists use in-vitro transcription templates to study gene expression, protein synthesis, and cellular mechanisms.

In-vitro Transcription Templates Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.09% over the forecast period (2024-2032)

Based on Product segmentation, the DNA templates segment was predicted to show maximum market share in the year 2023, owing to their higher efficiency in driving transcription.

Based on Application segmentation, vaccines segment was the leading Application segment in 2023, due to the growing prevalence of COVID-19 and other viral infections.

Based on Disease Type segmentation, cancer segment was the leading Disease Type segment in 2023, due to prevalence of lung cancer, leukemia, breast cancer, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the government support in research & new drugs development.

In-vitro Transcription Templates Market- Segmentation Analysis:

The Global In-vitro Transcription Templates Market is segmented on the basis of Product, Application, Disease Type, and Region.

The market is divided into four categories based on Product: DNA templates, RNA templates, templates & transcription kits, and others. The DNA templates segment dominates the market. DNA templates offer high efficiency & are robust in sequencing & transcription process which is contributing to market growth.

The market is divided into two categories based on Application: vaccines and therapeutics. The vaccines segment dominates the market. The vaccines are mainly used in targeting viral infections and are more effective than other type boosting market growth.

The market is divided into five categories based on Disease Type: cancer, infectious diseases, genetic diseases lifestyle diseases, and others. The cancer segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing prevalence of lung, breast cancer, leukemia are supplementing segment growth.

In-vitro Transcription Templates Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America held the largest revenue share in the global market. The U.S. dominates the global market due to its well-established biotechnology and pharmaceutical sectors, particularly in the development of RNA-based therapies and vaccines. In Asia Pacific, China is rapidly emerging as a key player in the IVT template market due to its growing biotech sector, increasing investments in RNA-based therapeutics, and government support for biotechnology R&D. Increased government focus on healthcare innovation and collaborations with global pharma companies are driving the market.

In-vitro Transcription Templates Market- Competitive Landscape:

The In-vitro Transcription (IVT) Templates market is significantly competitive, with several key players across the biotechnology and pharmaceutical industries focusing on innovations in RNA-based technologies. These companies are investing in developing high-quality transcription templates for RNA production, enabling advancements in areas like mRNA vaccines, RNA-based therapeutics, and gene editing. Key players are forming alliances with pharmaceutical companies to supply critical IVT components for the production of RNA-based vaccines and therapeutics. Companies like TriLink, Aldevron, and Merck are heavily investing in expanding their manufacturing capabilities, particularly for high-quality RNA production, to meet the growing demand for mRNA vaccines and RNA-based drugs.

In September 2023, Merck became the first CTDMO to offer fully integrated services for mRNA development, manufacturing, commercialization, and product testing.

In 2023, UK research councils such as the Medical Research Council (MRC) and the Biotechnology and Biological Sciences Research Council (BBSRC) allocated substantial funding for basic and applied research in RNA biology, genomics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET KEY PLAYERS

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

Table of Contents

1. In-vitro Transcription Templates Market Overview

2. Executive Summary

3. In-vitro Transcription Templates Key Market Trends

4. In-vitro Transcription Templates Industry Study

5. In-vitro Transcription Templates Market: COVID-19 Impact Analysis

6. In-vitro Transcription Templates Market Landscape

7. In-vitro Transcription Templates Market - By Product

8. In-vitro Transcription Templates Market - By Application

9. In-vitro Transcription Templates Market - By Disease Type

10. In-vitro Transcription Templates Market- By Geography

11. Key Vendor Analysis- In-vitro Transcription Templates Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â